Top Left Link Buttons
  • English
  • German

July 29, 2021

Daily Archives

Conference—Afghanistan: A Turning Point in History After the Failed Regime-Change Era

July 29, 2021by Mary Jane Freeman in Activity of the Schiller Institute, Economic development updates, General updates, Geopolitics updates, Global Diplomacy, Helga Zepp-LaRouche, Our conferences, Our economic development events
Become a member of the Schiller Institute

Schiller Institute International Conference – July 31, 2021

Afghanistan: A Turning Point in History
After the Failed Regime-Change Era

Moderator: Dennis Speed (U.S.), The Schiller Institute

Helga Zepp-LaRouche (Germany), Founder and President of The Schiller Institute
Keynote Address: “Afghanistan: The Bright Future for the Coming Cooperation of the Great Powers”

Pino Arlacchi (Italy), Sociology Professor at the Sassari University, Former Executive Director of the UN Office for Drug Control and Crime Prevention, and former European Parliament Rapporteur on Afghanistan
“Eradicate Opium in Afghanistan, Develop Modern Agriculture, Build the Nation, Now”

H.E. Ambassador Hassan Shoroosh (Afghanistan), Ambassador of the Islamic Republic of Afghanistan to Canada
“The Way Forward for Afghanistan”

H.E. Ambassador Anna Evstigneeva (Russian Federation), Deputy Permanent Representative at the Mission of The Russian Federation to the UN “Russia’s Outlook for Afghanistan and Eurasia”

Dr. Wang Jin (China), Fellow with The Charhar Institute
“Afghanistan and the Belt and Road Initiative”

Question and Answer Session

Ray McGovern (U.S.), Analyst, Central Intelligence Agency (CIA-ret.), Co-Founder, Veteran Intelligence Professionals for Sanity (VIPS)
“The Real Interest of the United States in Asia”

Hassan Daud (Pakistan), CEO, Khyber Pakhtunkhwa Province Board of Investment

“The Perspective from Pakistan: The Role of the Belt and Road Initiative (BRI) for Afghanistan Reconstruction.” 

Hussein Askary (Sweden/Iraq), Southwest Asia Coordinator for the Schiller Institute
“Put Afghanistan on the Belt and Road to Peace!”

Discussion Period

We welcome questions during the conference. Please send them to questions@schillerinstitute.org

Supplementary material by Executive Intelligence Review (EIR)—Special Report Offprint: ‘Will Afghanistan Trigger a Paradigm Change?’

PDF of the invitation

“After the hasty withdrawal of U.S. and NATO troops from Afghanistan—U.S. troops, except for a few security forces, were flown out in the dark of night without informing Afghan allies—this country has become, for the moment but likely not for long, the theater of world history.”
—Helga Zepp-LaRouche, July 10, 2021

We face an extraordinary moment, of further descent into chaos, or the beautiful potential of Afghanistan becoming the seed-crystal of a new era of international cooperation so desperately needed in the wake of growing disease and famine worldwide.

Afghanistan was once a hub for the ancient Silk Road, the connection between the great cultures of Asia and those of the European side of the Eurasian continent. The entire Central Asian region was once known as “a land of 1,000 cities”, showcasing advanced technologies in oasis cities, including Merv, Balkh, Kabul, and Kandahar, with large-scale underground irrigation systems. Water development will once again be crucial, and the agricultural potential is great.
In the past weeks, most of Afghanistan’s neighbors have come together, in an attempt to forge a commitment to end the nightmare suffered by the people of Afghanistan, a nightmare also suffered by the military forces of many nations drawn into needless combat in the service of a British-centered oligarchy fostering the growth of drug trafficking and terrorism in the entire region.

Just as the collapse of the Soviet Union marked the end of an era—the division of the world into nuclear armed blocs hostile to one another—so also the utter failure of the 20-year misadventure of the United States and NATO in Afghanistan, and in the other failed colonial wars in Southwest Asia, poses the question: Can the great nations of the world cooperate in the transformation of Afghanistan, and the other war-torn nations, into modern economies, participating in co-operative development through the New Silk Road process, exemplified by China’s Belt and Road Initiative?

Leading voices, from veterans’ groups and whistleblowers, to experts on the danger of global narcotics plague and on international political relations, will join Helga Zepp-LaRouche in dialogue, to impel the United States and Europe to join the growing international cooperation that is coming together. We can use this opportunity to make the turn from 50 years of failed policies, and instead to embark on the path required to achieve a new paradigm for mankind.

Webcast: Behind the Green New Deal— Hjalmar Schacht

July 29, 2021by David Dobrodt in General

In this week’s Dialogue, Helga Zepp-LaRouche takes no prisoners in characterizing the true nature of the “Green New Deal/Great Reset” agenda: nothing but a Schachtian policy for depopulation. She also reviews developments concerning the future of Afghanistan: will the U.S. join in cooperation with Russia, China, and other nations of the region to support Afghanistan’s economic development—perhaps the only chance to save the very fragile and tenuous relations with Russia and China—or, will the evil outlook of geopolitics prevail? That question should, as Zepp-LaRouche says, keep you up at night.

Register now for the July 31 Schiller Institute conference, “Afghanistan: A Turning Point in History After a Failed Regime Change Era.”

Kurchatov Institute To Create a Joint Russia-Belarus Scientific Research Center

July 29, 2021by Mary Jane Freeman in Belrus, Economic development updates, General updates, Global Diplomacy, Healthcare, Power & Energy, Russia, Space updates

Kurchatov Institute To Create a Joint Russia-Belarus Scientific Research Center–

July 28 (EIRNS)—The president of the Kurchatov Institute Scientific Research Center Mikhail Kovalchuk announced yesterday that his Institute and Belarus’s National Academy of Sciences had signed a roadmap to jointly establish “powerful projects related to new research infrastructure based on powerful installations—mega-sciences—[that] are now unfolding in front of us.”

Kovalchuk stated: “The program has also been launched in Russia and it is expected to become the world’s most accomplished research infrastructure in 5-7 years…. Importantly, both Belarus and Russia have the required tools. If we create this single infrastructural research space, we will become leaders in drawing other [Commonwealth of Independent States] CIS partners into this effort.”

He further said that “We have also proposed that a branch of the Kurchatov Institute be set up on the premises of the National Academy of Sciences of Belarus to strengthen integration and cooperation. Also, we proposed that a branch of the Moscow Engineering and Physics Institute be opened in Belarus in the field of new education.”

The TASS wire reporting on this announcement characterized the Kurchatov Institute National Research Center as “one of the leading research facilities in Russia and in the world. With its creation, Russia has set up a unique inter-disciplinary scientific and technical compound that comprises the Kurchatov specialized synchrotron radiation source (KISI-Kurchatov), the U-70 accelerator, the IR-8 and VVR-M neutron research reactors, the PIK high-flux research reactor, the T-10 and T-15 tokamak thermonuclear installations, plasma and other units.”

So. Korea Plans: Producing Up to 1 Billion Vaccines in 2022

July 29, 2021by Mary Jane Freeman in COVID-19, Economic development updates, General updates, Global Diplomacy, Healthcare, Healthcare, South Korea, United States

South Korea Plans for Producing Up to 1 Billion Vaccines in 2022—

July 28 (EIRNS)—While it remains to be seen how the U.S. will follow through on their commitment to assist India in ramping up COVID-19 vaccine production, the U.S.-Korea plans are moving forward. In India’s case, the U.S. has a bumpy history of blocking critical raw materials for India’s world-leading vaccine production operations, and then turning down repeated requests for vaccines when India was in the greatest need. And today, Antony Blinken offered a paltry, even insulting, $25 million for India’s vaccination program. No vaccines included.

On May 23, when South Korea’s President Moon Jae-in came to the White House, agreement was made on a Global Vaccine Partnership (GVP), first with a “KORUS GVP Experts Group” of scientists, public officials and various experts. Seoul had actually wanted immediate vaccines from the U.S. in exchange for future vaccines to be provided from Seoul to the U.S.—but that was refused. Instead, four deals were initiated, beginning with Samsung Biologics arrangement to produce “hundreds of millions” of Moderna vaccines, as soon as technology transfer and trial production were completed. South Korea would be putting up the money for purchasing the vaccines produced. Moderna also signed an MOU with the Ministry of Trade, Industry and Energy, and also the Ministry of Health and Welfare, for Moderna to invest in production facilities in Korea using a Korean workforce, with Korean government support for Moderna. Another MOU was signed by both the Health Ministry and SK Bioscience with the U.S.’s Novavax for vaccine development and production.

The update this month, from “a senior South Korean government official” is that Seoul is in talks with Pfizer and Moderna on expanding production up to 1 billion doses in 2022. (This is on top of deals with AstraZeneca and Novavax.) Health Ministry official Lee Kang-ho commented: “We have had frequent discussions with large pharmaceutical companies to produce mRNA vaccines. South Korea is keen to help by offering its facilities and skilled human resources.” The speculation is that Hanmi Pharmaceuticals and Quratis might be ready to start up production immediately. Hanmi said it has a large capacity reserved to produce Sanofi’s diabetes drug, but that is at a temporary standstill, and the capacity can meanwhile be used to produce COVID vaccines. And Quratis has a one-year-old factory which makes a tuberculosis vaccine, and they say they have capacity for mRNA vaccines. It appears that the technology, workforce and capital is all present, waiting to move forward.